Compounding Pharmaceutical Companies Pharmacy Technician 
Pharmacy Times
JUNE 24, 2025
This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.
Pharmacy Times
JUNE 23, 2025
In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. Based on this ruling, 505(b)(2) drugs that are not therapeutically interchangeable should be considered sole-source drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
National Association of Boards of Pharmacy
JULY 19, 2023
The resulting strain has made well-being and burnout one of the most concerning issues in pharmacy and pharmacy regulation today, affecting an increasing number of pharmacists, pharmacy technicians, and interns. In fact, some pharmaceutical companies have already been exploring similar functionality in specific use cases.
The Physician Pharmacist
NOVEMBER 2, 2023
And I think it's so interesting that you jumped into pharmacy without having like any experience in the field like prior to like working in retail. It's also really interesting that you were interested in medical school since pretty much the first year of pharmacy school. He's been in the compounding world for over a decade.
Pharmacy Times
JUNE 27, 2025
4,5 DREAMM-7 In DREAMM-7, patients with RRMM who had received at least 1 prior line of therapy were randomized 1:1 to receive belantamab mafodotin plus bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies) and dexamethasone (BVd) compared with daratumumab (Darzalex; Johnson & Johnson), bortezomib, and dexamethasone (DVd).
Expert insights. Personalized for you.
49 
Let's personalize your content